Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
_256_384.jpg)
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
Poviztra is a second brand of Wegovy
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
Subscribe To Our Newsletter & Stay Updated
